Catalog Number 06C29-27 |
Device Problem
False Positive Result (1227)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 09/11/2019 |
Event Type
malfunction
|
Manufacturer Narrative
|
Patient information, patient identifier: multiple = 936351018140, 936351908140, 935252468140 and 930553348140.All available patient information was included.Additional patient details are not available.An evaluation is in process.A final report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 6c29 that has a similar product distributed in the us, list number 6l27.
|
|
Event Description
|
The customer reported multiple false reactive architect havab-igg results.The samples were retested and generated non-reactive results.The following initial and retest results were provided: sample id 936351018140: 1.04 s/co and retest 0.82 s/co.Sample id 936351908140: 1.05 s/co and retest 0.24 s/co.Sample id 935252468140: 1.46 s/co and retests 0.39, 0.42, 1.20 s/co.Sample id 930553348140: 1.23 s/co and retest 0.28 s/co.No impact to patient management was reported.
|
|
Manufacturer Narrative
|
A review of complaint activity for the architect havab igg assay determined there is slightly elevated complaint activity for lot 03405be00.The tracking and trending report review did not identify any trends.Field data for the architect havab igg assay was reviewed as well as the performance of the likely cause lot, 03405be00.The review showed that the median and the standard deviations (sds) to cutoff of the negative population for lot 03405be00 was within established baselines.Therefore, the performance of the likely cause lot was determined to not be compromised.Manufacturing documentation was reviewed, and no issues were identified.Additionally, labeling was reviewed and sufficiently addresses the customers issue.Based on the investigation, no systemic issue or deficiency of the architect havab igg assay was identified.
|
|
Search Alerts/Recalls
|
|